Literature DB >> 2722351

Oral contraception, smoking and inflammatory bowel disease--findings in the Royal College of General Practitioners Oral Contraception Study.

R F Logan1, C R Kay.   

Abstract

Data from the Royal College of General Practitioners Oral Contraception Study have been examined to determine whether oral contraceptive use was associated with the development of Crohn's disease or ulcerative colitis. Over a 17 year period Crohn's disease developed in 42 women and ulcerative colitis in 78. The incidence of both diseases was greater in oral contraceptive users compared to non-users with the rate ratio for Crohn's disease being 1.7 (95% confidence limits, 0.88, 3.2) and for ulcerative colitis being 1.3 (95% confidence limits 0.82, 2.0). For both diseases incidence was unrelated to parity or social class, but women smoking at recruitment had a greater incidence of Crohn's disease (rate ratio 1.8, 95% confidence limits 0.93, 3.3) and a reduced incidence of ulcerative colitis (rate ratio 0.68, 95% confidence limits 0.41, 1.1). Although these results are based on small numbers and could be chance findings, they are consistent with other studies showing associations between oral contraceptive use, smoking and the development of Crohn's disease and ulcerative colitis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2722351     DOI: 10.1093/ije/18.1.105

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  13 in total

1.  Smoking, use of oral contraceptives, and medical induction of remission were risk factors for relapse in Crohn's disease.

Authors:  R F Logan
Journal:  Gut       Date:  1999-03       Impact factor: 23.059

2.  Smoking and inflammatory bowel diseases: what in smoking alters the course?

Authors:  A M El-Tawil
Journal:  Int J Colorectal Dis       Date:  2010-03-24       Impact factor: 2.571

3.  A prospective study of cigarette smoking and the risk of inflammatory bowel disease in women.

Authors:  Leslie M Higuchi; Hamed Khalili; Andrew T Chan; James M Richter; Athos Bousvaros; Charles S Fuchs
Journal:  Am J Gastroenterol       Date:  2012-07-10       Impact factor: 10.864

4.  Association between maternal inflammatory bowel disease and adverse perinatal outcomes.

Authors:  D Getahun; M J Fassett; G F Longstreth; C Koebnick; A M Langer-Gould; D Strickland; S J Jacobsen
Journal:  J Perinatol       Date:  2014-03-20       Impact factor: 2.521

5.  A comprehensive analysis of 12 thrombophilic mutations and related parameters in patients with inflammatory bowel disease: data from Turkey.

Authors:  Serif Yilmaz; Kadim Bayan; Yekta Tüzün; Sabri Batun; Abdullah Altintaş
Journal:  J Thromb Thrombolysis       Date:  2006-12       Impact factor: 2.300

Review 6.  Hygiene hypothesis in inflammatory bowel disease: a critical review of the literature.

Authors:  Natasha-A Koloski; Laurel Bret; Graham Radford-Smith
Journal:  World J Gastroenterol       Date:  2008-01-14       Impact factor: 5.742

7.  Hospitalized prevalence and 5-year mortality for IBD: record linkage study.

Authors:  Lori A Button; Stephen E Roberts; Michael J Goldacre; Ashley Akbari; Sarah E Rodgers; John G Williams
Journal:  World J Gastroenterol       Date:  2010-01-28       Impact factor: 5.742

8.  A meta-analysis of the role of smoking in inflammatory bowel disease.

Authors:  B M Calkins
Journal:  Dig Dis Sci       Date:  1989-12       Impact factor: 3.199

9.  Environmental influences on the onset and clinical course of Crohn's disease-part 2: infections and medication use.

Authors:  Adam M Berg; Aamir N Dam; Francis A Farraye
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-12

10.  Meta-analysis of the role of oral contraceptive agents in inflammatory bowel disease.

Authors:  P G Godet; G R May; L R Sutherland
Journal:  Gut       Date:  1995-11       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.